XML 80 R69.htm IDEA: XBRL DOCUMENT v3.5.0.2
SHAREHOLDERS' EQUITY (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 10, 2016
Mar. 27, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Increase (Decrease) in Shareholders' Equity            
Beginning Balance (in shares)         342,926,531  
Beginning Balance         $ 6,029.8 $ 5,401.7
Issuance of common stock (in shares) 213,610 7,286,432        
Issuance of common stock   $ 1,450.0       1,481.0
Common shares issued under share-based compensation plans         4.5 22.1
Repurchases of common shares           (50.0)
Share-based compensation         97.2 60.9
Employee withholding taxes related to share-based awards         (7.3) (61.5)
Excess tax benefits from share-based compensation         (1.4) 25.6
Noncontrolling interest distributions         (9.1) (1.1)
Total before comprehensive income (loss)     $ 6,113.7 $ 6,878.7 6,113.7 6,878.7
Comprehensive loss:            
Net (loss) income     (304.0) (51.6) (676.9) 46.9
Other comprehensive loss         (33.7) (376.0)
Comprehensive loss     $ (401.2) (15.7) $ (710.6) (329.1)
Ending Balance (in shares)     343,030,673   343,030,673  
Ending Balance     $ 5,403.1 6,549.6 $ 5,403.1 6,549.6
Valeant Pharmaceuticals International, Inc. Shareholders’ Equity            
Increase (Decrease) in Shareholders' Equity            
Beginning Balance         5,911.0 5,279.4
Issuance of common stock           1,481.0
Common shares issued under share-based compensation plans         4.5 22.1
Repurchases of common shares           (50.0)
Share-based compensation         97.2 60.9
Employee withholding taxes related to share-based awards         (7.3) (61.5)
Excess tax benefits from share-based compensation         (1.4) 25.6
Total before comprehensive income (loss)     6,004.0 6,757.5 6,004.0 6,757.5
Comprehensive loss:            
Net (loss) income         (676.0) 44.7
Other comprehensive loss         (32.1) (375.6)
Comprehensive loss         (708.1) (330.9)
Ending Balance     $ 5,295.9 $ 6,426.6 $ 5,295.9 $ 6,426.6
Common Shares            
Increase (Decrease) in Shareholders' Equity            
Beginning Balance (in shares)         342,900,000 334,400,000
Beginning Balance         $ 9,897.4 $ 8,349.2
Issuance of common stock (in shares)           7,500,000
Issuance of common stock           $ 1,481.0
Common shares issued under share-based compensation plans (in shares)         100,000 1,100,000
Common shares issued under share-based compensation plans         $ 17.5 $ 57.0
Repurchase of commons shares (in shares)           (200,000)
Repurchases of common shares           $ (6.4)
Total before comprehensive income (loss) (in shares)     343,000,000 342,800,000 343,000,000 342,800,000
Total before comprehensive income (loss)     $ 9,914.9 $ 9,880.8 $ 9,914.9 $ 9,880.8
Comprehensive loss:            
Ending Balance (in shares)     343,000,000 342,800,000 343,000,000 342,800,000
Ending Balance     $ 9,914.9 $ 9,880.8 $ 9,914.9 $ 9,880.8
Additional Paid-In Capital            
Increase (Decrease) in Shareholders' Equity            
Beginning Balance         304.9 243.9
Common shares issued under share-based compensation plans         (13.0) (34.9)
Share-based compensation         97.2 60.9
Employee withholding taxes related to share-based awards         (7.3) (61.5)
Excess tax benefits from share-based compensation         (1.4) 25.6
Total before comprehensive income (loss)     380.4 234.0 380.4 234.0
Comprehensive loss:            
Ending Balance     380.4 234.0 380.4 234.0
Accumulated Deficit            
Increase (Decrease) in Shareholders' Equity            
Beginning Balance         (2,749.7) (2,397.8)
Repurchases of common shares           (43.6)
Total before comprehensive income (loss)     (2,749.7) (2,441.4) (2,749.7) (2,441.4)
Comprehensive loss:            
Net (loss) income         (676.0) 44.7
Ending Balance     (3,425.7) (2,396.7) (3,425.7) (2,396.7)
Accumulated Other Comprehensive Loss            
Increase (Decrease) in Shareholders' Equity            
Beginning Balance         (1,541.6) (915.9)
Total before comprehensive income (loss)     (1,541.6) (915.9) (1,541.6) (915.9)
Comprehensive loss:            
Other comprehensive loss         (32.1) (375.6)
Ending Balance     (1,573.7) (1,291.5) (1,573.7) (1,291.5)
Noncontrolling Interest            
Increase (Decrease) in Shareholders' Equity            
Beginning Balance         118.8 122.3
Noncontrolling interest distributions         (9.1) (1.1)
Total before comprehensive income (loss)     109.7 121.2 109.7 121.2
Comprehensive loss:            
Net (loss) income         (0.9) 2.2
Other comprehensive loss         (1.6) (0.4)
Comprehensive loss         (2.5) 1.8
Ending Balance     $ 107.2 $ 123.0 $ 107.2 $ 123.0